Palmoplantar Pustulosis
Palmoplantar Pustulosis
RIST4721-202 Enrolling

Palmoplantar Pustulosis Research Trial (20 weeks)

Treatment: Oral Age: 18 Years

Adults aged 18 to less than 75 years with a physician-confirmed diagnosis of palmoplantar pustulosis (PPP) for at least 6 months, may qualify to participate.  Eligible individuals must have moderate to severe disease, and show a lack of response or tolerability to local standard of care therapy for PPP or be contraindicated to such therapies.

Participants will receive investigational oral medication (active study drug) or placebo, in tablet form.  Study medication and study-related assessments will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last about 20 weeks and involve about 7 visits to the study centre.

Participating Locations

Participating Experts

Dr. Anil Kurian


Dr. Charles Lynde


Dr. Maryam Shayesteh Alam


You May Also Be Interested In

Similar Trials

No Similar Trials Found

Learn More About

Palmoplantar Pustulosis

Learn More
2022 all rights reserved probity medical research inc
find a trial
filter trials